GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

PROF · Sep 30, 2025

Profound Medical Corp.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]

Inspectable configuration

State dimensions

Filing0001104659-25-111378General Corporate

Debt relative to revenueRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.debt_to_revenue

88.56% · OPTIONAL · NOT_ENOUGH_HISTORY

Operating cash generationRAWCurrent state valid · history insufficient

Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-190.04% · OPTIONAL · NOT_ENOUGH_HISTORY

Inventory pressureRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

164.80% · OPTIONAL · NOT_ENOUGH_HISTORY

Gross marginRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.gross_margin

77.70% · CORE · NOT_ENOUGH_HISTORY

Operating marginRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.operating_margin

-176.18% · CORE · NOT_ENOUGH_HISTORY

R&D intensityRAWCurrent state valid · history insufficient

Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

107.10% · OPTIONAL · NOT_ENOUGH_HISTORY

SBC intensityRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

32.99% · OPTIONAL · NOT_ENOUGH_HISTORY

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History7 statesHistory building

Dec 31, 20240/7 normalizedLevel 3 Mar 31, 20250/7 normalizedLevel 3 Jun 30, 20250/7 normalizedLevel 3 Sep 30, 20250/7 normalizedLevel 3 Dec 31, 20250/9 normalizedLevel 3 Mar 31, 20260/8 normalizedLevel 3 Jun 30, 20260/8 normalizedLevel 3

Period transition

What moved in the state?

Balance Sheet Leverage Decreased

Previous: 225.24%
Current: 88.56%
Delta: -136.68%

Cash Generation Increased

Previous: -693.79%
Current: -190.04%
Delta: 503.75%

Inventory Pressure Decreased

Previous: 421.66%
Current: 164.80%
Delta: -256.86%

Margin Decreased

Previous: 81.68%
Current: 77.70%
Delta: -3.97%

Profitability Increased

Previous: -696.92%
Current: -176.18%
Delta: 520.74%

R And D Intensity Decreased

Previous: 307.82%
Current: 107.10%
Delta: -200.73%

Sbc Intensity Decreased

Previous: 73.25%
Current: 32.99%
Delta: -40.26%

Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.

Research Graph

Related governed research

Transitioned To · PROF Fundamental State →Has State · Profound Medical Corp. →Transitioned To · PROF Fundamental State →Transitioned To · PROF BALANCE_SHEET_LEVERAGE_DECREASED →Transitioned To · PROF CASH_GENERATION_INCREASED →Transitioned To · PROF INVENTORY_PRESSURE_DECREASED →Transitioned To · PROF MARGIN_DECREASED →Transitioned To · PROF PROFITABILITY_INCREASED →Transitioned To · PROF R_AND_D_INTENSITY_DECREASED →Transitioned To · PROF SBC_INTENSITY_DECREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.